Fry Laboratories, L.L.C. is an independent clinical diagnostic and research laboratory located in Scottsdale, Arizona.
We are committed to understanding chronic diseases and contributing to their cure through advancements in diagnostics and basic science research with emphasis on chronic inflammatory diseases, vector-borne diseases, and their intersection. Our clinical diagnostic laboratory offers general and targeted immunology services in conjunction with standard and cutting edge infectious disease detection and identification technologies. Our signature services include microscopy for visual identification and quantification of a wide range of blood-borne pathogens, co-infection serology, biofilm detection, and genus wide molecular detection technology with sequencing for individualized species identification. We participate in both CAP and API quality control programs and provide worldwide testing service.
Diseases of Interest: Chronic Fatigue Syndrome, Fibromyalgia, Gulf War Veterans Illness, Chronic Lyme Disease, ALS (Lou Gehrig’s Disease), Parkinson’s Disease, Multiple Sclerosis, Lupus, Scleroderma, Rheumatoid Arthritis, Osteoarthritis, and Vascular Disease.
Organisms of Interest: Borrelia (Lyme), Babesia, Bartonella, Anaplasma, Ehrlichia, Coxiella (Q-Fever), Toxoplasma, Rickettsia, Plasmodium, and Novel Biofilm Forming Eukaryotes.
In addition to being the Founder, Director, and Principal Investigator of our laboratory, Stephen E. Fry, M.S., M.D., was previously a General Practitioner based in Scottsdale. Dr. Fry first became interested in autoimmune diseases in 1992, after seeing the debilitating effects that these diseases can have on patients. Dr. Fry’s busy clinical practice, as well as his interest in analyzing the causative agents of autoimmune disease, have led to the development of our lab. A large portion of Dr. Fry’s patients include those who suffer from chronic fatigue, fibromyalgia, lyme disease, and other complicated autoimmune diseases. Dr. Fry is a member of I.L.A.D.S., the A.M.A., the Arizona Biotechnology Consortium, the I.S.N.V.D., and he holds many patents on cutting edge biotechnological and diagnostic innovations.